Harmony Biosciences (HRMY): O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti
Harmony Biosciences narkolepsiya dori vositalarining monopol narxlari va arzon autsorsingdan foydalangan holda foydani oshirmoqda. Uning nevrologik klinikalari tarmog'ining kengayishi kamyob patologiyalarning tashxisini yaxshilashga yordam bermoqda. PEG koeffitsiyenti baholash dinamikasini ko'rsatadi, bunda 0.45 oxirgi darajani ifodalaydi. Nuqsonsiz tibbiy obro' va spekulyatorlar ustidan qozonilgan g'alaba emitentning moliyaviy barqarorligini tasdiqlaydi.
Harmony Corp (HRMY) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- balans kapitallashuvi ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Harmony Biosciences|HRMY - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Harmony Pharma|HRMY - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Harmony Corp|HRMY - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Harmony Biosciences|Oraliq qoplama koeffitsiyenti harmonybiosciences.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
HRMY - Kompaniyaning sof foydasi|Kutilayotgan sof foyda Harmony Biosciences|HRMY - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Harmony Biosciences|HRMY - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Harmony Corp|HRMY - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Harmony Biosciences|HRMY - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi harmonybiosciences.com|HRMY - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Harmony Biosciences
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:Harmony Pharma, HRMY
Harmony Biosciences o'zining patentlangan uyqu dori vositalari uchun sotuv xarajatlarining pastligi tufayli yuqori masshtablanish imkoniyatiga ega, bu esa foydaning tez o'sishi uchun asos yaratadi. 0.45 ga teng bo'lgan joriy PEG koeffitsiyenti aktivning haddan tashqari qimmat baholanganini aniqlash uchun P/E ko'rsatkichini ushbu o'sish sur'atlari bilan solishtiradi; birdan past qiymat kompaniyaning kengayishiga nisbatan fundamental jihatdan past baholanganini anglatadi.
Raqobatdosh kompaniyalar
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Idec|Neurocrine Corp - Narx-foyda va o‘sish multiplikatori|regencellbioscience.com (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|ACAD (ACADIA Pharmaceuticals Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Xenon Pharmaceuticals (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narxning foydaga va o‘sish sur’atiga nisbati Supernus|O‘sish sur’atiga tuzatilgan narx-foyda catalystpharma.com CPRX|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics Inc.)|BHVN - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Amylyx Pharmaceuticals, Inc. AMLX|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVI|PRAX - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Anavex Life Sciences AVXL|CBLL: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Prothena Corporation PLC|ALEC (alector.com) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Annexon, Inc. (ANNX)|Narxning foydaga va o‘sish sur’atiga nisbati Omeros Corporation (OMER)|Neurogene Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|acimmune.com - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning sof foyda o‘sishiga nisbati Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ACOG|Narxning foydaga va o‘sish sur’atiga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SAVA (Cassava)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - PEG multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Narx-foyda va o‘sish multiplikatori|CRVO (CervoMed, Inc.) - Narx-foyda va o‘sish multiplikatori|Narx-foyda va o‘sish multiplikatori Alterity Therapeutics Ltd|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc.|PepGen Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori JUNS (Jupiter Neurosciences Inc)|Narxning foydaga va o‘sish sur’atiga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - PEG multiplikatori|Klotho Neurosciences (KLTO) - Narx-foyda va o‘sish multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori Passage Bio Inc. (PASG)|Narxning foydaga va o‘sish sur’atiga nisbati bionomics.com.au NEUP|PEG multiplikatori Minerva Neurosciences Inc NERV|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN (Addex Therapeutics, Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Alzamend Neuro Inc. (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati protagenic.com|Pasithea Therapeutics - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CRGT (Cortigent, Inc.)|Avenue Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell BCLI|PEG multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG multiplikatori|eliemtx.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Intra-Cellular Therapies (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|LBPH (Longboard) - Narxning foydaga va o‘sish sur’atiga nisbati|MRNS (marinuspharma.com) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharma (NRBO)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAGE|Synaptogenix, Inc. - Narx-foyda va o‘sish multiplikatori|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti WENA (Anew Medical, Inc.)|CERE: PEG multiplikatori
